SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-039163
Filing Date
2008-06-17
Accepted
2008-06-17 14:31:11
Documents
1
Period of Report
2008-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 OPTION GRANT rrd211054.html 4  
1 FORM 4 OPTION GRANT rrd211054.xml 4 3735
  Complete submission text file 0001181431-08-039163.txt   5669
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address C/O CHELSEA THERAPEUTICS, INC. 3530 TORINGDON WAY, SUITE 200 CHARLOTTE NC 28277
Business Address 704-341-1516
Oliveto Joseph (Reporting) CIK: 0001437782 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51462 | Film No.: 08902872